
Vikrama Simhapuri University (VSU) signed a Memorandum of Understanding with Malladi Drugs and Pharmaceuticals Limited on Wednesday, 18 November 2026, to give pharmacy students practical exposure. Vice-Chancellor Allam Srinivasa Rao and Malladi general manager A. Narayana exchanged documents at the university campus in Nellore.

The MoU covers industrial training, internships, research, and skill programmes. It will teach students pharmaceutical manufacturing, quality control, quality assurance, and good manufacturing practices. The university said the tie-up would improve employment opportunities.
Registrar K. Suneetha stressed the importance of industry-academia collaboration. Malladi's Narayana assured support through training and expert interactions. No further steps have been announced.
The coverage from The Hindu and Deccan Chronicle is nearly uniform, both reporting the signing of an MoU between VSU and Malladi Drugs with identical facts, signatories, purpose (industrial training, internships, research), and benefits cited. The Hindu includes a direct quote from Malladi's Narayana on student skills and Company assurance of support, while Deccan Chronicle quotes Registrar K. Suneetha on industry-academia collaboration absent from The Hindu. No framing difference emerges, as both outlets reproduce the university and company press statements without critical or independent questioning. The story, in both versions, is straight institutional coverage with no adversarial angle. Neither outlet names a next step beyond the MoU being signed on 18 November 2026.
Coverage: 2 sources, 2 neutral
Sources (2): thehindu.com (neutral report), deccanchronicle.com (neutral report)
This brief was synthesised by AI from the 2 sources linked above, so one read covers every framing they carry. Methodology and corrections.